James M N Duffy1, Janneke van 't Hooft2, Chris Gale3, Mark Brown4, William Grobman5, Ray Fitzpatrick6, S Ananth Karumanchi7, Nuala Lucas8, Laura Magee9, Ben Mol10, Michael Stark10, Shakila Thangaratinam11, Mathew Wilson12, Peter von Dadelszen9, Paula Williamson13, Khalid S Khan11, Sue Ziebland14, Richard J McManus14. 1. Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6NW, United Kingdom. Electronic address: james.duffy@balliol.ox.ac.uk. 2. Academical Medical Centre, Amsterdam 1105 AZ, Netherlands. 3. Academic Neonatal Medicine, Imperial College London, Chelsea and Westminster Campus, 369 Fulham Road, London SW10 9NH, United Kingdom. 4. Renal Unit, St George and Sutherland Hospitals, 14-18 Regent St, Kogarah, NSW 2217, Australia. 5. Department of Obstetrics and Gynaecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, United States. 6. Health Services Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, United Kingdom. 7. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States. 8. Obstetric Anaesthetists' Association, 21 Portland Place, London W1B 1PY, United Kingdom. 9. St George's, University of London, Cranmer Terrace, London SW17 0RE, United Kingdom. 10. Department of Obstetrics and Gynaecology, University of Adelaide, Adelaide 5005, Australia. 11. Women's Health Research Unit, Barts and the London School of Medicine and Dentistry, London E1 2AB, United Kingdom. 12. School of Health and Related Research, University of Sheffield, Sheffield S10 2TN, United Kingdom. 13. MRC North West Hub for Trials Methodology Research, Institute of Translation Medicine, University of Liverpool, Liverpool L69 3BX, United Kingdom. 14. Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6NW, United Kingdom.
Abstract
BACKGROUND: Pre-eclampsia is a serious complication of pregnancy and contributes to maternal and offspring mortality and morbidity. Randomised controlled trials evaluating therapeutic interventions for pre-eclampsia have reported many different outcomes and outcome measures. Such variation contributes to an inability to compare, contrast, and combine individual studies, limiting the usefulness of research to inform clinical practice. The development and use of a core outcome set would help to address these issues ensuring outcomes important to all stakeholders, including patients, will be collected and reported in a standardised fashion. METHODS: An international steering group including healthcare professionals, researchers, and patients, has been formed to guide the development of this core outcome set. Potential outcomes will be identified through a comprehensive literature review and semi-structured interviews with patients. Potential core outcomes will be entered into an international, multi-perspective online Delphi survey. All key stakeholders, including healthcare professionals, researchers, and patients will be invited to participate. The modified Delphi method encourages whole and stakeholder group convergence towards consensus 'core' outcomes. Once core outcomes have been agreed upon it is important to determine how they should be measured. The truth, discrimination, and feasibility assessment framework will assess the quality of potential outcome measures. High quality outcome measures will be associated with core outcomes. Mechanisms exist to disseminate and implement the resulting core outcome set within an international context. DISCUSSION: Embedding the core outcome set within future clinical trials, systematic reviews, and clinical practice guidelines could make a profound contribution to advancing the usefulness of research to inform clinical practice, enhance patient care, and improve maternal and offspring outcomes. The infrastructure created by developing a core outcome set for pre-eclampsia could be leveraged in other settings, for example selecting research priorities and clinical practice guideline development. PROSPECTIVE REGISTRATION: [1] Core Outcome Measures in Effectiveness Trials (COMET) registration number: 588. [2] International Prospective Register of Systematic Reviews (PROSPERO) registration number: CRD42015015529.
BACKGROUND: Pre-eclampsia is a serious complication of pregnancy and contributes to maternal and offspring mortality and morbidity. Randomised controlled trials evaluating therapeutic interventions for pre-eclampsia have reported many different outcomes and outcome measures. Such variation contributes to an inability to compare, contrast, and combine individual studies, limiting the usefulness of research to inform clinical practice. The development and use of a core outcome set would help to address these issues ensuring outcomes important to all stakeholders, including patients, will be collected and reported in a standardised fashion. METHODS: An international steering group including healthcare professionals, researchers, and patients, has been formed to guide the development of this core outcome set. Potential outcomes will be identified through a comprehensive literature review and semi-structured interviews with patients. Potential core outcomes will be entered into an international, multi-perspective online Delphi survey. All key stakeholders, including healthcare professionals, researchers, and patients will be invited to participate. The modified Delphi method encourages whole and stakeholder group convergence towards consensus 'core' outcomes. Once core outcomes have been agreed upon it is important to determine how they should be measured. The truth, discrimination, and feasibility assessment framework will assess the quality of potential outcome measures. High quality outcome measures will be associated with core outcomes. Mechanisms exist to disseminate and implement the resulting core outcome set within an international context. DISCUSSION: Embedding the core outcome set within future clinical trials, systematic reviews, and clinical practice guidelines could make a profound contribution to advancing the usefulness of research to inform clinical practice, enhance patient care, and improve maternal and offspring outcomes. The infrastructure created by developing a core outcome set for pre-eclampsia could be leveraged in other settings, for example selecting research priorities and clinical practice guideline development. PROSPECTIVE REGISTRATION: [1] Core Outcome Measures in Effectiveness Trials (COMET) registration number: 588. [2] International Prospective Register of Systematic Reviews (PROSPERO) registration number: CRD42015015529.
Authors: Allison Tong; John Gill; Klemens Budde; Lorna Marson; Peter P Reese; David Rosenbloom; Lionel Rostaing; Germaine Wong; Michelle A Josephson; Timothy L Pruett; Anthony N Warrens; Jonathan C Craig; Benedicte Sautenet; Nicole Evangelidis; Angelique F Ralph; Camilla S Hanson; Jenny I Shen; Kirsten Howard; Klemens Meyer; Ronald D Perrone; Daniel E Weiner; Samuel Fung; Maggie K M Ma; Caren Rose; Jessica Ryan; Ling-Xin Chen; Martin Howell; Nicholas Larkins; Siah Kim; Sobhana Thangaraju; Angela Ju; Jeremy R Chapman Journal: Transplantation Date: 2017-08 Impact factor: 4.939
Authors: Katherine C Whitehouse; Caron R Kim; Bela Ganatra; James M N Duffy; Jennifer Blum; Dalia Brahmi; Mitchell D Creinin; Teresa DePiñeres; Kristina Gemzell-Danielsson; Daniel Grossman; Beverly Winikoff; A Metin Gülmezoglu Journal: Contraception Date: 2017-01-05 Impact factor: 3.375
Authors: James William Harrison Webbe; James M N Duffy; Elsa Afonso; Iyad Al-Muzaffar; Ginny Brunton; Anne Greenough; Nigel J Hall; Marian Knight; Jos M Latour; Caroline Lee-Davey; Neil Marlow; Laura Noakes; Julie Nycyk; Angela Richard-Löndt; Ben Wills-Eve; Neena Modi; Chris Gale Journal: Arch Dis Child Fetal Neonatal Ed Date: 2019-11-15 Impact factor: 5.747
Authors: J M N Duffy; S Bhattacharya; C Curtis; J L H Evers; R G Farquharson; S Franik; Y Khalaf; R S Legro; S Lensen; B W Mol; C Niederberger; E H Y Ng; S Repping; A Strandell; H L Torrance; A Vail; M van Wely; N L Vuong; A Y Wang; R Wang; J Wilkinson; M A Youssef; C M Farquhar Journal: Hum Reprod Open Date: 2018-06-15
Authors: Simen Vergote; Felix De Bie; Jan Bosteels; Holly Hedrick; James Duffy; Beverley Power; Alexandra Benachi; Paolo De Coppi; Caraciolo Fernandes; Kevin Lally; Irwin Reiss; Jan Deprest Journal: Trials Date: 2021-02-23 Impact factor: 2.279
Authors: Constantin M Durnea; Vasilios Pergialiotis; James M N Duffy; Lina Bergstrom; Abdullatif Elfituri; Stergios K Doumouchtsis Journal: Int Urogynecol J Date: 2018-10-22 Impact factor: 2.894